Methyl 3-iodo-1H-pyrazolo[3,4-b]pyridine-5-carboxylate, 95.0%, 2.5g

2-Bromo-N,N-dimethylpyridine-4-amine, 95.0%, 5g

Cyclohexyl anthranilate, 98.0%, 1g

2-(2-((Bicyclo[2.2.1]hept-5-en-2-ylmethyl)amino)ethoxy)ethan-1-ol, 97%, 2.5g

3-(2-phenylhydrazin-1-ylidene)cyclohexan-1-one, 95%, 50mg

tert-butyl N-[2-(1-hydroxyethyl)phenyl]carbamate, 95.0%, 2g

2-Nitro-5-methylbenzoic acid, 95.0%, 5g

quinoxalin-5-ylmethanamine;hydrochloride, 95, 100mg

6,8-DIHYDRO-8-OXOISOBENZOFURO[5,4-D][1,3]DIOXOLE-6-CARBOXYLIC ACID, 90.0%, 250mg

1H-Pyrazole-3,5-dicarboxylic acid, 97.0%, 10g

3-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine, 95.0%, 250mg

N-(2-BROMOETHYL)-3-FLUORO-N-METHYLANILINE, 95.0%, 1g

GC capillary column ROTI®Cap-1, 25 m, 0.20 mm, 0.20 µm, 1 Piece(s)